Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1091 | 991 | 1091 | 1201 | 1266 | 1830 |
Fund Return | 9.07% | -0.9% | 9.07% | 6.29% | 4.83% | 6.23% |
Place in category | 308 | 382 | 308 | 147 | 152 | 67 |
% in Category | 50 | 61 | 50 | 28 | 32 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Fund | 5.16B | 9.15 | 6.45 | 6.28 | ||
Royal London European Growth Fund C | 2.29B | -0.14 | 1.53 | 7.95 | ||
Royal London US Tracker Z Fund Accu | 1.29B | 26.97 | 11.20 | 14.97 | ||
Royal London UK Equity Income Fund | 1.12B | 7.45 | 6.65 | 6.47 | ||
Royal London UK Equity Income M | 1.12B | 7.36 | 6.60 | 6.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VG UK Institutional Plus GBP Income | 15.15B | 11.15 | 7.79 | 6.11 | ||
All Share Index Unit Trust Income | 15.15B | 11.14 | 7.78 | 6.09 | ||
VG UK Plus GBP Accumulation | 15.15B | 11.14 | 7.80 | 6.12 | ||
Index Unit Trust Accumulation | 15.15B | 9.33 | 5.76 | 6.10 | ||
UK Equity Tracker Fund D Acc | 11.63B | 9.28 | 6.08 | 6.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.49 | 11,052.0 | +2.39% | |
Shell | GB00BP6MXD84 | 6.46 | 32.12 | -0.77% | |
HSBC | GB0005405286 | 5.58 | 825.50 | +0.02% | |
Unilever | GB00B10RZP78 | 4.77 | 54.74 | +0.33% | |
ICF FTSE 100 IDX FUT DEC24 | GB00KKY7ZY67 | 3.98 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review